|
Male/female (n)
|
11/22
|
8/10
|
0.547
|
|
Age (years)
|
30.03 ± 7.96
|
27.33 ± 7.89
|
0.252
|
|
Time from onset (months)
|
5(0.5, 60)
|
3(0.33, 84)
|
0.501
|
|
With/without prior infection
|
13/20
|
10/8
|
0.378
|
|
With/without gross hematuria
|
16/17
|
9/9
|
1.000
|
|
Systolic blood pressure (mmHg)
|
118.18 ± 10.95
|
115.28 ± 13.98
|
0.416
|
|
Diastolic blood pressure (mmHg)
|
74.24 ± 8.11
|
71.11 ± 10.51
|
0.241
|
|
Proteinuria (g/24 h)
|
0.52 ± 0.20
|
0.62 ± 0.24
|
0.149
|
|
Serum creatinine (μmol/L)
|
74.24 ± 13.09
|
75.69 ± 13.10
|
0.707
|
|
eGFR(ml/min/1.73 m2)
|
105.24 ± 23.19
|
104.56 ± 16.27
|
0.912
|
|
Serum IgA (mg/dL)
|
318.05 ± 111.82
|
374.27 ± 127.36
|
0.180
|
|
Serum Complement 3 (mg/dL)
|
93.73 ± 23.15
|
96.38 ± 19.04
|
0.774
|
|
Mesangial hypercellularity (M0/M1)
|
29/4
|
13/5
|
0.249
|
|
Segmental glomerulosclerosis (S0/S1)
|
28/5
|
17/1
|
0.405
|
|
Endocapillary hypercellularity (E0/E1)
|
29/4
|
15/3
|
0.686
|
|
Tubular atrophy/interstitial fibrosis (T0/T1/T2)
|
33/0/0
|
13/5/0
|
0.004*
|
|
With/without extracapillary proliferation (cresecents)
|
6/27
|
9/9
|
0.026*
|
|
With/without global glomerulosclerosis
|
13/20
|
10/8
|
0.378
|
|
With/without vascular lesions
|
6/27
|
8/10
|
0.057
|
